262 related articles for article (PubMed ID: 32705271)
1. Shikonin blocks human lung adenocarcinoma cell migration and invasion in the inflammatory microenvironment via the IL‑6/STAT3 signaling pathway.
Pan T; Zhang F; Li F; Gao X; Li Z; Li X; Ren X
Oncol Rep; 2020 Sep; 44(3):1049-1063. PubMed ID: 32705271
[TBL] [Abstract][Full Text] [Related]
2. Wogonin suppresses human alveolar adenocarcinoma cell A549 migration in inflammatory microenvironment by modulating the IL-6/STAT3 signaling pathway.
Zhao Y; Yao J; Wu XP; Zhao L; Zhou YX; Zhang Y; You QD; Guo QL; Lu N
Mol Carcinog; 2015 Jun; 54 Suppl 1():E81-93. PubMed ID: 24976450
[TBL] [Abstract][Full Text] [Related]
3. Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition.
Hsieh YS; Liao CH; Chen WS; Pai JT; Weng MS
J Cell Biochem; 2017 Dec; 118(12):4639-4651. PubMed ID: 28485480
[TBL] [Abstract][Full Text] [Related]
4. LFG-500, a novel synthetic flavonoid, suppresses epithelial-mesenchymal transition in human lung adenocarcinoma cells by inhibiting NLRP3 in inflammatory microenvironment.
Yang D; Cao X; Wang F; Jiang H; Feng D; Guo H; Du L; Jin Y; Chen Y; Yin X; Li C
Cancer Lett; 2017 Aug; 400():137-148. PubMed ID: 28461245
[TBL] [Abstract][Full Text] [Related]
5. Icariside II inhibits the EMT of NSCLC cells in inflammatory microenvironment via down-regulation of Akt/NF-κB signaling pathway.
Song J; Feng L; Zhong R; Xia Z; Zhang L; Cui L; Yan H; Jia X; Zhang Z
Mol Carcinog; 2017 Jan; 56(1):36-48. PubMed ID: 26859114
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rh4 Suppressed Metastasis of Lung Adenocarcinoma via Inhibiting JAK2/STAT3 Signaling.
Zhang Y; Ma P; Duan Z; Liu Y; Mi Y; Fan D
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216134
[TBL] [Abstract][Full Text] [Related]
7. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
8. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.
Zhang FY; Hu Y; Que ZY; Wang P; Liu YH; Wang ZH; Xue YX
Int J Mol Sci; 2015 Oct; 16(10):23823-48. PubMed ID: 26473829
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
10. Shikonin suppresses colon cancer cell growth and exerts synergistic effects by regulating ADAM17 and the IL‑6/STAT3 signaling pathway.
Shi W; Men L; Pi X; Jiang T; Peng D; Huo S; Luo P; Wang M; Guo J; Jiang Y; Peng L; Lin L; Li S; Lv J
Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34726248
[TBL] [Abstract][Full Text] [Related]
11. Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways.
Yang Q; Ji M; Guan H; Shi B; Hou P
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1909-17. PubMed ID: 24106286
[TBL] [Abstract][Full Text] [Related]
12. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
13. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.
Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC
Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331
[TBL] [Abstract][Full Text] [Related]
14. Traditional Chinese medicine, Fuzheng Kang‑Ai decoction, inhibits metastasis of lung cancer cells through the STAT3/MMP9 pathway.
Li L; Wang S; Yang X; Long S; Xiao S; Wu W; Hann SS
Mol Med Rep; 2017 Sep; 16(3):2461-2468. PubMed ID: 28677797
[TBL] [Abstract][Full Text] [Related]
15. STEAP1 facilitates metastasis and epithelial-mesenchymal transition of lung adenocarcinoma via the JAK2/STAT3 signaling pathway.
Huo SF; Shang WL; Yu M; Ren XP; Wen HX; Chai CY; Sun L; Hui K; Liu LH; Wei SH; Wang XX; Wang Y; Tian YX
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515474
[TBL] [Abstract][Full Text] [Related]
16. Enhanced invasion of lung adenocarcinoma cells after co-culture with THP-1-derived macrophages via the induction of EMT by IL-6.
Dehai C; Bo P; Qiang T; Lihua S; Fang L; Shi J; Jingyan C; Yan Y; Guangbin W; Zhenjun Y
Immunol Lett; 2014 Jul; 160(1):1-10. PubMed ID: 24698728
[TBL] [Abstract][Full Text] [Related]
17. [SP13786 Inhibits the Migration and Invasion of Lung Adenocarcinoma Cell A549
by Supressing Stat3-EMT via CAFs Exosomes].
Wang S; Cui J; Zhang K; Gu J; Zheng Y; Zhang B; Shi L
Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):384-393. PubMed ID: 34024061
[TBL] [Abstract][Full Text] [Related]
18. Shikonin enhances sensitization of gefitinib against wild-type EGFR non-small cell lung cancer via inhibition PKM2/stat3/cyclinD1 signal pathway.
Tang JC; Ren YG; Zhao J; Long F; Chen JY; Jiang Z
Life Sci; 2018 Jul; 204():71-77. PubMed ID: 29738778
[TBL] [Abstract][Full Text] [Related]
19. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKKβ/NFκB signal cascade.
Zhao J; Zhang Q; Zou G; Gao G; Yue Q
J Ethnopharmacol; 2020 Mar; 250():112492. PubMed ID: 31866511
[TBL] [Abstract][Full Text] [Related]
20. OGT regulated O-GlcNacylation promotes migration and invasion by activating IL-6/STAT3 signaling in NSCLC cells.
Ge X; Peng X; Li M; Ji F; Chen J; Zhang D
Pathol Res Pract; 2021 Sep; 225():153580. PubMed ID: 34391182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
